Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
about
WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer CellsCryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathwaysPhysalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells.Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease.Overexpression of JAK2: a predictor of unfavorable prognosis for nasopharyngeal carcinoma.IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.Investigation of JAKs/STAT-3 in lipopolysaccharide-induced intestinal epithelial cells.Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells.Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting "Trojan Horse" Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance.Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3.Targeting tumour microenvironment by tyrosine kinase inhibitor.Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
P2860
Q33634911-369B244F-4650-4B28-ADF0-53BE23AE2A75Q35680729-BD5AA394-6254-45CB-96BD-BA8C7DD37122Q36277354-5A7316FB-E4E4-43CD-B255-E0FB870407B9Q36546515-A91FD857-3C43-4D06-A180-D980C232DB15Q36962642-8F1FC124-65B2-428A-A922-CBF3A5630F2AQ37164378-3FACA778-BB4A-41EE-927A-E8CB2BB57AE5Q38801418-37507458-F543-4ECC-9C5A-75CA002D2452Q38880087-318FA5E7-A7DC-4B35-BF6B-8EEFBB48F3F1Q40041190-F6A26FD8-F4D8-4F85-BBB4-EC679047E6E3Q41863613-50452534-FDA9-4508-94C7-7D90F6C428FEQ42773885-076650BE-5703-4ED8-B78B-4F75A50FE34BQ46415201-77F33FDC-DCAE-4A60-B391-BF07CFD4BD62Q47148273-3D0C0755-F969-45A2-BB72-D6F12FD265DDQ47253710-F98363DA-F85E-4D92-AA70-0C2C262144B9Q48159682-05C0A108-B5E7-4D25-A5FD-772B64C82FADQ49130713-770B355C-14DE-432E-A4D7-537A75F71EDDQ49641330-C2675D7B-9163-4D5C-89E3-087B0C0E0021Q49887906-59DD4F22-274E-4977-98E2-D531C2150454Q50696151-1D54A05E-EE16-4A68-8F34-1E01887AEC60Q52595261-F9264BB9-FDFB-4E83-A4B2-FD9B8D12B742Q55084775-6B0EFEFB-3774-4526-A3C3-C9714CBF3FE1Q55269538-EAB398D7-AC06-480B-B9BD-3BF8A0211674Q58572515-84599F06-1DF4-45C9-9136-D4218FB7E907
P2860
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@ast
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@en
type
label
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@ast
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@en
prefLabel
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@ast
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@en
P2093
P2860
P1476
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
@en
P2093
Denise C Connolly
Dennis Huszar
Emmanuelle Nicolas
Galina Gritsina
Luis J Sigal
Marisa A Maglaty
Rashid Gabbasov
Ren-Huan Xu
Roshan J Thapa
P2860
P304
P356
10.1158/1535-7163.MCT-14-0800
P577
2015-02-02T00:00:00Z